Thompson David E. 4
4 · Anthera Pharmaceuticals Inc · Filed May 10, 2012
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2012-05-08+12,000→ 12,000 totalExercise: $1.79Exp: 2022-05-07→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of May 8, 2012. This stock option is fully exercisable on May 8, 2013.